Because retatrutide is not yet licensed in the UK, individuals are unlikely to encounter it outside of a formal clinical trial setting
Furthermore, they can provide expert guidance on the nutritional, lifestyle, and holistic skincare interventions necessary to support your bodys natural ability to heal and rejuvenate
Without resistance training and adequate protein, GLP1 patients risk long-term harm even as they look thinner
AOM semaglutide also showed its largest quarter-over-quarter percentage point increase since the start of the study period, a trend likely driven by approval of the oral formulation of Wegovy in late 2025
Stickle has developed a program tailored for this GLP-1 user group, using a metabolism-first approach with tailored nutrition focusing on preserving muscle, energy, and long-term metabolic health